ClinicalTrials.gg
RecruitingNCT07776847Updated Aug 24, 2026

The Effect of Ultrasonographic Airway Measurements and Anatomical Differences on Laryngeal Mask Placement in Young and Older Adults

An observational study in Airway Management and Laryngeal Mask Airway Insertion Skill, sponsored by Duzce University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by Duzce University · Observational

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
188
Ages
18 Years and older
Sex
All
01

Study summary

This prospective observational study aims to compare ultrasonographic upper-airway measurements and age-related anatomical differences between young adults (18-40 years) and older adults (>65 years), and to evaluate their effects on laryngeal mask airway (LMA) placement success and position accuracy. Preoperative airway ultrasonography measurements will be assessed, followed by evaluation of LMA placement, ventilation efficacy, insertion attempts, placement time, and complications. Ultrasonography will also be used to assess LMA position after placement, with confirmation by leak testing and fiberoptic evaluation. Preoperative and postoperative gastric volume will additionally be assessed.

Read the detailed description

Laryngeal mask airway use is common in general anesthesia. Age-related anatomical and physiological changes of the upper airway may influence LMA placement in older adults. The study will prospectively evaluate patients undergoing procedures suitable for LMA placement at Düzce University Faculty of Medicine. Participants will be divided into young adults (18-40 years) and older adults (>65 years). Demographic, anthropometric, clinical airway assessment and ultrasonographic airway measurements will be recorded. Following standardized induction, a ProSeal LMA will be placed by an anesthesia research resident with at least three years of experience. The number of insertion attempts and placement time will be recorded. LMA position will be assessed by ultrasonography and compared with leak testing and fiberoptic confirmation. Ventilation parameters, cuff pressure, LMA position changes, gastric volume and postoperative complications will also be recorded.

02

Conditions studied

  • Airway Management
  • Laryngeal Mask Airway Insertion Skill

Keywords

  • Laryngeal mask airway
  • airway ultrasonography
  • geriatrics
03

In context

Lead sponsor

Duzce University is the lead sponsor of 76 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients scheduled for elective surgery under general anesthesia with planned laryngeal mask airway use will be enrolled. The study population will include two age-based groups: young adults aged 18-40 years with ASA physical status I-II, and older adults aged 65 years or above with ASA physical status I-III. Eligible participants will be patients with intact neck anatomy and clinical suitability for supraglottic airway management. Patients with BMI >35 kg/m², pregnancy, known obstructive sleep apnea, significant neck deformity or prior diagnostic/therapeutic neck procedures, or mouth opening \<2.5 cm will be excluded.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient or legally appropriate representative/relative accepts participation as applicable.
  • Surgery suitable for LMA placement.
  • Age 18-40 years or >65 years.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Age \<18 years
  • History of upper airway surgery
  • Gastroesophageal reflux disease, ulcer, or gastrointestinal bleeding history
  • Inadequate fasting duration
  • Emergency surgery
  • Requirement for nasogastric tube placement
  • Unstable teeth
  • Mouth opening \<3 cm
  • Recent pulmonary infection
  • Recent upper airway infection
  • Pulmonary disease associated with increased airway pressures (cystic fibrosis, , interstitial lung disease)
  • Restricted cervical movement / inability to achieve required extension
  • Ultrasound gel allergy
  • Refusal to participate
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
188 participants (estimated)
Patient registry
No

Groups and cohorts

  • young patient

    Young adult patients aged 18-40

  • older patient

    Adult patients over the age of 65

06

What researchers measure

Primary outcomes

  1. First-attempt successful LMA placement rate

    The primary outcome will compare the proportion of successful first-attempt ProSeal LMA placements between young and older adult groups.

    Time frame: During LMA insertion

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2025 (actual). Primary completion is estimated for Jul 2027, 24 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 17, 2026
First posted
Aug 20, 2026
StartActual
Jul 1, 2025
Primary completionEst.
Jul 30, 2027
CompletionEst.
Aug 30, 2027
Last update
Aug 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07776847
Lead sponsor
Duzce University
Responsible party
Gizem Demir Şenoğlu (Ass. Prof.; M.D., Duzce University) — Principal investigator
First posted
Aug 20, 2026
Start date
Jul 1, 2025
Primary completion
Jul 30, 2027 (estimated)
Completion
Aug 30, 2027 (estimated)
Last update
Aug 24, 2026

Study contacts

Zennur Güven, Assistant Researcher
Contact
zennurguven@gmail.com
+90 5459740213

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion